1. Siegelaar SE, Holleman F, Hoekstra JBL, DeVries JH. Glucose Variability; Does It Matter. Endocrine Reviews 2010;31(2):171-182. Available from: http://press.endocrine.org/doi/abs/10.1210/er.2009-0021 doi: 10.1210/er.2009-0021.
2. Di Flaviani A, Picconi F, Di Stefano P, Giordani I, Malandrucco I, Maggio P, et al. Impact of Glycemic and Blood Pressure Variability on Surrogate Measures of Cardiovascular Outcomes in Type 2 Diabetic Patients. Diabetes Care 2011;34(7):1605-1609. Available from: http://care.diabetesjournals.org/cgi/doi/10.2337/dc11-0034 PubMed PMID: 21610126. doi: 10.2337/dc11-0034.
3. Herrero P, Bondia J, Palerm CC, Vehi J, Georgiou P, Oliver N, et al. A Simple Robust Method for Estimating the Glucose Rate of Appearance from Mixed Meals. Journal of Diabetes Science and Technology 2012;6(1):153-162. Available from: http://dst.sagepub.com/lookup/doi/10.1177/193229681200600119 PubMed PMID: 22401334. doi: 10.1177/193229681200600119.
4. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol J, et al. Activation of Oxidative Stress by Acute Glucose Fluctuations Compared With Sustained Chronic Hyperglycemia in Patients With Type 2 Diabetes. JAMA 2006;295(14):1681-1687. Available from: http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.295.14.1681 PubMed PMID: 16609090. doi: 10.1001/jama.295.14.1681.
5. Древаль АВ, Редькин ЮА, Богомолов ВВ. Корреляция уровня HbA1c и постпрандиальной гликемии в пероральном тесте толерантности к глюкозе у больных сахарным диабетом 2-го типа. Проблемы эндокринологии. 2007;53(1):10-8. [Dreval' AV, Red'kin AR, Bogomolov VV. Correlation Level of HbA1c and postprandial glycemia in type 2 diabetes in the oral glucose tolerance test. Problemy endokrinologii 2007;53(1):10-18.]
6. McDonnell CM, Donath SM, Vidmar SI, Werther GA, Cameron FJ. A Novel Approach to Continuous Glucose Analysis Utilizing Glycemic Variation. Diabetes Technology & Therapeutics 2005;7(2):253-263. Available from: http://online.liebertpub.com/doi/abs/10.1089/dia.2005.7.253 PubMed PMID: 15857227. doi: 10.1089/dia.2005.7.253.
7. Ryan EA, Shandro T, Green K, Paty BW, Senior PA, Bigam D, et al. Assessment of the Severity of Hypoglycemia and Glycemic Lability in Type 1 Diabetic Subjects Undergoing Islet Transplantation. Diabetes 2004;53(4):955-962. Available from: http://diabetes.diabetesjournals.org/cgi/doi/10.2337/diabetes.53.4.955 PubMed PMID: 15047610. doi: 10.2337/diabetes.53.4.955.
8. Kovatchev BP, Otto E, Cox D, Gonder-Frederick L, Clarke W. Evaluation of a new measure of blood glucose variability in diabetes.. Diabetes Care 2006;29(11):2433-2438. Available from: http://www.scholaruniverse.com/ncbi-linkout?id=17065680 PubMed PMID: 17065680. doi: 10.2337/dc06-1085.
9. Kovatchev BP, Cox DJ, Farhy LS, Straume M, Gonder-Frederick L, Clarke WL. Episodes of severe hypoglycemia in type 1 diabetes are preceded and followed within 48 hours by measurable disturbances in blood glucose. J Clin Endocrinol Metab 2000;85(11):4287-4292. Available from: http://www.nlm.nih.gov/medlineplus/bloodsugar.html PubMed PMID: 11095469. doi: 10.1210/jcem.85.11.6999.
10. Kovatchev BP, Cox DJ, Kumar A, Gonder-Frederick L, Clarke WL. Algorithmic Evaluation of Metabolic Control and Risk of Severe Hypoglycemia in Type 1 and Type 2 Diabetes Using Self-Monitoring Blood Glucose Data. Diabetes Technology & Therapeutics 2003;5(5):817-828. Available from: http://online.liebertpub.com/doi/abs/10.1089/152091503322527021 PubMed PMID: 14633347. doi: 10.1089/152091503322527021.
11. HillNR, NickSO, ChoudharyP, LevyJC, HindmarshP, MatthewsDR . Normal Reference Range for Mean Tissue Glucose and Glycemic Variability Derived from Continuous Glucose Monitoring for Subjects Without Diabetes in Different Ethnic Groups. Diabetes Technol Ther 2011;13(9):921-928. Available from: http://online.liebertpub.com/doi/abs/10.1089/dia.2010.0247 PubMed PMID: 21714681. doi: 10.1089/dia.2010.0247.
12. Kohnert KD, Vogt L, Augstein P, Heinke P, Zander E, Peterson K, et al. Relationships between Glucose Variability and Conventional Measures of Glycemic Control in Continuously Monitored Patients with Type 2 Diabetes. Horm Metab Res 2009;41(02):137-141. Available from: http://www.thieme-connect.de/DOI/DOI?10.1055/s-0028-1128143 PubMed PMID: 19214924. doi: 10.1055/s-0028-1128143.
13. Pitsillides AN, Anderson SM, Kovatchev B. Hypoglycemia Risk and Glucose Variability Indices Derived from Routine Self-Monitoring of Blood Glucose Are Related to Laboratory Measures of Insulin Sensitivity and Epinephrine Counterregulation. Diabetes Technology & Therapeutics 2011;13(1):11-17. Available from: http://online.liebertpub.com/doi/abs/10.1089/dia.2010.0103 PubMed PMID: 21175266. doi: 10.1089/dia.2010.0103.
14. Patton SR, Clements MA. Average daily risk range as a measure for clinical research and routine care. J Diabetes Sci Technol 2013;7(5):1370-1375. PubMed PMID: 24124966.
15. Hill NR, Hindmarsh PC, Stevens RJ, Stratton IM, Levy JC, Matthews DR. A method for assessing quality of control from glucose profiles. Diabetic Med 2007;24(7):753-758. Available from: http://doi.wiley.com/10.1111/j.1464-5491.2007.02119.x doi: 10.1111/j.1464-5491.2007.02119.x.
16. Molnar GD, Taylor WF, Ho MM. Day-to-day variation of continuously monitored glycaemia: A further measure of diabetic instability. Diabetologia 1972;8(5):342-348. Available from: http://link.springer.com/10.1007/BF01218495 PubMed PMID: 4641791. doi: 10.1007/BF01218495.
17. Kilpatrick ES, Rigby AS, Atkin SL. A1C Variability and the Risk of Microvascular Complications in Type 1 Diabetes: Data from the Diabetes Control and Complications Trial. Diabetes Care 2008;31(11):2198-2202. Available from: http://care.diabetesjournals.org/cgi/doi/10.2337/dc08-0864 PubMed PMID: 18650371. doi: 10.2337/dc08-0864.
18. Waden J, Forsblom C, Thorn LM, Gordin D, Saraheimo M, Groop PH. A1C Variability Predicts Incident Cardiovascular Events, Microalbuminuria, and Overt Diabetic Nephropathy in Patients With Type 1 Diabetes. Diabetes 2009;58(11):2649-2655. Available from: http://diabetes.diabetesjournals.org/cgi/doi/10.2337/db09-0693 PubMed PMID: 19651819. doi: 10.2337/db09-0693.
19. Chen T, Xu F, Su J, Wang X, Chen J, Wu G, et al. Glycemic variability in relation to oral disposition index in the subjects with different stages of glucose tolerance. Diabetol Metab Syndr 2013;5(1):38. Available from: http://www.dmsjournal.com/content/5/1/38 PubMed PMID: 23876034. doi: 10.1186/1758-5996-5-38.
20. Kilpatrick ES, Rigby AS, Atkin SL. The Effect of Glucose Variability on the Risk of Microvascular Complications in Type 1 Diabetes. Diabetes Care 2006;29(7):1486-1490. Available from: http://care.diabetesjournals.org/cgi/doi/10.2337/dc06-0293 PubMed PMID: 16801566. doi: 10.2337/dc06-0293.
21. Kilpatrick ES, Rigby AS, Atkin SL. Effect of Glucose Variability on the Long-Term Risk of Microvascular Complications in Type 1 Diabetes. Diabetes Care 2009;32(10):1901-1903. Available from: http://care.diabetesjournals.org/cgi/doi/10.2337/dc09-0109 PubMed PMID: 19549736. doi: 10.2337/dc09-0109.
22. Hietala K, Wadén J, Forsblom C, Harjutsalo V, Kytö J, Summanen P, et al. HbA1c variability is associated with an increased risk of retinopathy requiring laser treatment in type 1 diabetes. Diabetologia 2013;56(4):737-745. Available from: http://link.springer.com/10.1007/s00125-012-2816-6 PubMed PMID: 23314044. doi: 10.1007/s00125-012-2816-6.
23. Muggeo M, Zoppini G, Bonora E, Brun E, Bonadonna RC, Moghetti P, et al. Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study. Diabetes Care 2000;23(1):45-50. Available from: http://care.diabetesjournals.org/cgi/doi/10.2337/diacare.23.1.45 PubMed PMID: 10857967. doi: 10.2337/diacare.23.1.45.
24. Muggeo M, Verlato G, Bonora E, Zoppini G, Corbellini M, deMarco R. Long-term Instability of Fasting Plasma Glucose, a Novel Predictor of Cardiovascular Mortality in Elderly Patients With Non Insulin-Dependent Diabetes Mellitus : The Verona Diabetes Study. Circulation 1997;96(6):1750-1754. Available from: http://circ.ahajournals.org/cgi/doi/10.1161/01.CIR.96.6.1750 doi: 10.1161/01.CIR.96.6.1750.
25. Mo Y, Zhou J, Li M, Wang Y, Bao Y, Ma X, et al. Glycemic variability is associated with subclinical atherosclerosis in Chinese type 2 diabetic patients. Cardiovasc Diabetol 2013;12(1):15-1186. Available from: http://www.cardiab.com/content/12/1/15 PubMed PMID: 23316958. doi: 10.1186/1475-2840-12-15.
26. Zhang X, Xu X, Jiao X, Wu J, Zhou S, Lv X. The effects of glucose fluctuation on the severity of coronary artery disease in type 2 diabetes mellitus. J Diabetes Res 2013;2013:576916-1155. Available from: http://dx.doi.org/10.1155/2013/576916 PubMed PMID: 23936867. doi: 10.1155/2013/576916.
27. Su G, Mi S, Tao H, Li Z, Yang H, Zheng H, et al. Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes. Cardiovasc Diabetol 2011;10(1):19-1186. Available from: http://www.cardiab.com/content/10/1/19 PubMed PMID: 21349201. doi: 10.1186/1475-2840-10-19.
28. Починка ИГ, Стронгин ЛГ, Стручкова ЮВ. Вариабельность гликемии и желудочковые нарушения ритма у больных с хронической сердечной недостаточностью, страдающих сахарным диабетом 2 типа. Кардиология. 2013;53(9):47-51. [Pochinka IG, Strongin LG, Struchkova Yu V . Variability of Glycemia and Ventricular Rhythm Disturbances in Patients With Chronic Heart Failure and Type 2 Diabetes Mellitus. Kardiologiia 2013;53(9):47-51.].
29. Su G, Mi S, Li Z, Tao H, Yang H, Zheng H. Prognostic value of early in-hospital glycemic excursion in elderly patients with acute myocardial infarction. Cardiovasc Diabetol 2013;12(1):33. Available from: http://www.cardiab.com/content/12/1/33 doi: 10.1186/1475-2840-12-33.
30. Su G, Mi SH TH, Li Z, Yang HX, Zheng H, Zhou Y, et al. Impact of Admission Glycemic Variability, Glucose, and Glycosylated Hemoglobin on Major Adverse Cardiac Events After Acute Myocardial Infarction. Diabetes Care 2013;36(4):1026-1032. Available from: http://care.diabetesjournals.org/cgi/doi/10.2337/dc12-0925 PubMed PMID: 23349547. doi: 10.2337/dc12-0925.
31. Subramaniam B, Lerner A, Novack V, Khabbaz K, Paryente-Wiesmann M, Hess P, et al. Increased Glycemic Variability in Patients with Elevated Preoperative HbA1C Predicts Adverse Outcomes Following Coronary Artery Bypass Grafting Surgery. Anesthesia & Analgesia 2014;118(2):277-287. Available from: http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00000539-201402000-00008 PubMed PMID: 24445629. doi: 10.1213/ANE.0000000000000100.
32. Piconi L, Quagliaro L, Assaloni R, Da Ros R, Maier A, Zuodar G, et al. Constant and intermittent high glucose enhances endothelial cell apoptosis through mitochondrial superoxide overproduction. Diabetes Metab. Res. Rev 2006;22(3):198-203. Available from: http://doi.wiley.com/10.1002/dmrr.613 PubMed PMID: 16453381. doi: 10.1002/dmrr.613.
33. WentholtI ME, Kulik W, Michels RPJ, HoekstraJ BL, DeVries JH. Glucose fluctuations and activation of oxidative stress in patients with type 1 diabetes. Diabetologia 2008;51(1):183-190.
34. Ceriello A, Esposito K, Piconi L, Ihnat MA, Thorpe JE, Testa R, et al. Oscillating Glucose Is More Deleterious to Endothelial Function and Oxidative Stress Than Mean Glucose in Normal and Type 2 Diabetic Patients. Diabetes 2008;57(5):1349-1354. Available from: http://diabetes.diabetesjournals.org/cgi/doi/10.2337/db08-0063 PubMed PMID: 18299315. doi: 10.2337/db08-0063.
35. Azuma K. Repetitive Fluctuations in Blood Glucose Enhance Monocyte Adhesion to the Endothelium of Rat Thoracic Aorta. Arteriosclerosis, Thrombosis, and Vascular Biology 2006;26(10):2275-2280. Available from: http://atvb.ahajournals.org/cgi/doi/10.1161/01.ATV.0000239488.05069.03 PubMed PMID: 16888238. doi: 10.1161/01.ATV.0000239488.05069.03.
36. El-Osta A, Brasacchio D, Yao D, Pocai A, Jones PL, Roeder RG, et al. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. Journal of Experimental Medicine 2008;205(10):2409-2417. Available from: http://www.jem.org/cgi/doi/10.1084/jem.20081188 doi: 10.1084/jem.20081188.
37. Ceriello PA. OXIDATIVE STRESS AND DIABETES-ASSOCIATED COMPLICATIONS. Endocrine Practice 2006;12(s1):60-62. Available from: http://aace.metapress.com/openurl.asp?genre=article&id=doi:10.4158/EP.12.S1.60 PubMed PMID: 16627383. doi: 10.4158/EP.12.S1.60.
38. Бондарь ИА, Климонтов ВВ. Иммуновоспалительные механизмы в формировании диабетической нефропатии. Проблемы эндокринологии. 2007;53(2):34-40. [Bondar' IA, Klimontov VV. Immune inflammatory mechanisms in the development of diabetic nephropathy. Problemy endokrinologii. 2007;53(2):34-40.]
39. Derr R, Garrett E, Stacy GA, Saudek CD. Is HbA1c Affected by Glycemic Instability. Diabetes Care 2003;26(10):2728-2733. Available from: http://care.diabetesjournals.org/cgi/doi/10.2337/diacare.26.10.2728 PubMed PMID: 14514571. doi: 10.2337/diacare.26.10.2728.
40. Kohnert K, Augstein P, Heinke P, Zander E, Peterson K, Freyse E, et al. Chronic hyperglycemia but not glucose variability determines HbA1c levels in well-controlled patients with type 2 diabetes. Diabetes Research and Clinical Practice 2007;77(3):420-426. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0168822707000599 doi: 10.1016/j.diabres.2007.01.021.
41. Kilpatrick ES, Rigby AS, Goode K, Atkin SL. Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes. Diabetologia 2007;50(12):2553-2561. Available from: http://link.springer.com/10.1007/s00125-007-0820-z PubMed PMID: 17882397. doi: 10.1007/s00125-007-0820-z.
42. Williams ME, Garg R, Wang W, Lacson R, Maddux F, Lacson E. High Hemoglobin A1c levels and glycemic variability increase risk of severe hypoglycemia in diabetic hemodialysis patients. Hemodial Int 2013;18(2):423-432. Available from: http://doi.wiley.com/10.1111/hdi.12110 PubMed PMID: 24274900. doi: 10.1111/hdi.12110.
43. Klimontov VV, Tsiberkin AI, Fazullina ON, Prudnikova MA, Tyan NV, Konenkov VI. Glucose variability and hypoglycaemic excursions in elderly type 2 diabetic patients treated with insulin. Diabetologia 2013;56(Suppl.1):239.
44. Dagogo-Jack SE, Craft S, Cryer PE. Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia. J. Clin. Invest 1993;91(3):819-828. Available from: http://www.jci.org/articles/view/116302 PubMed PMID: 8450063. doi: 10.1172/JCI116302.
45. Pitsillides AN, Anderson SM, Kovatchev B. Hypoglycemia Risk and Glucose Variability Indices Derived from Routine Self-Monitoring of Blood Glucose Are Related to Laboratory Measures of Insulin Sensitivity and Epinephrine Counterregulation. Diabetes Technology & Therapeutics 2011;13(1):11-17. Available from: http://online.liebertpub.com/doi/abs/10.1089/dia.2010.0103 PubMed PMID: 21175266. doi: 10.1089/dia.2010.0103.
46. Bragd J, Adamson U, Bäcklund LB, Lins PE, Moberg E, Oskarsson P. Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade. Diabetes & Metabolism 2008;34(6):612-616. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1262363608001651 doi: 10.1016/j.diabet.2008.04.005.
47. Pérez-Maraver M, Caballero-Corchuelo J, Boltana A, Insa R, Soler J, Montanya E. Comparison of human insulin and insulin analogues on hypoglycaemia and metabolic variability in type 1 diabetes using standardized measurements (HYPO score and Lability Index. Acta Diabetol 2013;50(4):529-535. Available from: http://link.springer.com/10.1007/s00592-011-0320-y doi: 10.1007/s00592-011-0320-y.
48. Bruttomesso D, Crazzolara D, Maran A, Costa S, Dal Pos M , Girelli A, et al. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine. Diabet Med 2008;25(3):326-332. Available from: http://www.nlm.nih.gov/medlineplus/bloodsugar.html PubMed PMID: 18307459. doi: 10.1111/j.1464-5491.2007.02365.x.
49. McCall AL, Cox DJ, Brodows R, Crean J, Johns D, Kovatchev B. Reduced Daily Risk of Glycemic Variability: Comparison of Exenatide with Insulin Glargine. Diabetes Technology & Therapeutics 2009;11(6):339-344. Available from: http://online.liebertpub.com/doi/abs/10.1089/dia.2008.0107 PubMed PMID: 19459761. doi: 10.1089/dia.2008.0107.
50. Shimoda S, Iwashita S, Ichimori S, Matsuo Y, Goto R, Maeda T, et al. Efficacy and safety of sitagliptin as add-on therapy on glycemic control and blood glucose fluctuation in Japanese type 2 diabetes subjects ongoing with multiple daily insulin injections therapy. Endocr J 2013;60(10):1207-1214. Available from: http://jlc.jst.go.jp/DN/JST.JSTAGE/endocrj/EJ13-0198?lang=en&from=CrossRef&type=abstract PubMed PMID: 23912974. doi: 10.1507/endocrj.EJ13-0198.
51. Rodbard D, Bailey T, Jovanovic L, Zisser H, Kaplan R, Garg SK. Improved Quality of Glycemic Control and Reduced Glycemic Variability with Use of Continuous Glucose Monitoring. Diabetes Technology & Therapeutics 2009;11(11):717-723. Available from: http://online.liebertpub.com/doi/abs/10.1089/dia.2009.0077 PubMed PMID: 19905888. doi: 10.1089/dia.2009.0077.